Trials / Unknown
UnknownNCT04673227
Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)
Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI) and the Influence of Previous BCG Vaccination - Pilot Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Thomayer University Hospital · Academic / Other
- Sex
- All
- Age
- 4 Years – 70 Years
- Healthy volunteers
- —
Summary
TB-reactive immune cells will be tested in a multiparametric flow cytometry to distinguish an immune response for antigens of Mycobacterium spp. in TB disease/latent infection or a reaction after BCG vaccine.
Detailed description
The goal of this project is the verification of current cytometric panel of detection antibodies in a wider panel of stimulative immunodominant antigens for CD4+ and CD8+ T cells in combination with adjuvants 2 in a in vitro activating test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood draw | Blood draw and the analysis of blood in laboratory |
Timeline
- Start date
- 2020-01-02
- Primary completion
- 2020-05-26
- Completion
- 2022-12-26
- First posted
- 2020-12-17
- Last updated
- 2020-12-17
Locations
2 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT04673227. Inclusion in this directory is not an endorsement.